EUVIMEDEUVIMED entdecken
Leserbrief

Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long‐term follow‐up of the EORTC‐GIMEMA randomized AML ‐10 trial

Frédéric Baron iD, Fabio Efficace iD, Laura Cannella, Marian Stevens-Kroef, Sergio Amadori, Theo de Witte, Michael Lübbert, Adriano Venditti iD, Stefan Suciu

American Journal of Hematology · 2024

DOI: 10.1002/ajh.27196 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Frédéric Baron und 8 weiteren Autor:innen. Beteiligte Einrichtung: Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Laboratory of Hematology, University of Liège, Liège, Belgium. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Peripheral Blood Stem Cells. Die Arbeit nennt 6 Literaturangaben. Gefördert von: Stichting Tegen Kanker, Fonds De La Recherche Scientifique - FNRS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcutePeripheral Blood Stem CellsHumansBone MarrowBone Marrow TransplantationFollow-Up StudiesProspective StudiesRemission InductionTransplantation, AutologousRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Laboratory of Hematology, University of Liège, Liège, Belgium.
  • Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.
  • Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
  • Department of Hematology, Sapienza University, Rome, Italy.
  • EORTC Headquarters, Brussels, Belgium.

ORCID-Profile: Frédéric Baron, Fabio Efficace, Adriano Venditti

Förderung

  • Stichting Tegen Kanker
  • Fonds De La Recherche Scientifique - FNRS

Zitieren

APA

Baron, F., Efficace, F., Cannella, L., Stevens-Kroef, M., Amadori, S., de Witte, T., Lübbert, M., Venditti, A., & Suciu, S. (2024). Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long‐term follow‐up of the EORTC‐GIMEMA randomized AML ‐10 trial. American Journal of Hematology. https://doi.org/10.1002/ajh.27196

Vancouver

Baron F, Efficace F, Cannella L, Stevens-Kroef M, Amadori S, de Witte T, et al. Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long‐term follow‐up of the EORTC‐GIMEMA randomized AML ‐10 trial. American Journal of Hematology. 2024. doi:10.1002/ajh.27196

BibTeX
@article{Baron2024,
  author = {Baron, Frédéric and Efficace, Fabio and Cannella, Laura and Stevens-Kroef, Marian and Amadori, Sergio and de Witte, Theo and Lübbert, Michael and Venditti, Adriano and Suciu, Stefan},
  title = {Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long‐term follow‐up of the EORTC‐GIMEMA randomized AML ‐10 trial},
  journal = {American Journal of Hematology},
  year = {2024},
  doi = {10.1002/ajh.27196}
}
Kostenlos starten →